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Abstract:
Background - The American Heart Association’s (AHA) 2020 Strategic Impact Goals target a 
20% relative improvement in overall cardiovascular health using 4 health behavior (smoking, 
diet, physical activity, body mass) and 3 health factor (plasma glucose, cholesterol, blood 
pressure) metrics. We sought to define current trends and forward projections to 2020 in 
cardiovascular health. 
Methods and Results - We included 35,059 CVD-free adults (?20 years old) from the National 
Health and Nutrition Examination Survey 1988-94 and subsequent 2-year cycles from 1999 to 
2008. We calculated population prevalence of poor, intermediate, and ideal health behaviors and 
factors, and also computed a composite, individual-level Cardiovascular Health Score for all 7 
metrics (poor=0 points; intermediate=1 point; ideal=2 points; total range 0-14 points). 
Prevalence of current and former smoking, hypercholesterolemia, and hypertension declined, 
whereas prevalence of obesity and dysglycemia increased through 2008. Physical activity levels 
and low diet quality scores changed minimally. Projections to 2020 suggest that obesity and 
impaired fasting glucose/diabetes could increase to affect 43% and 77% of US men, and 42% 
and 53% of US women, respectively.  Overall, population-level cardiovascular health is 
projected to improve by 6% overall by 2020 if current trends continue. Individual-level 
Cardiovascular Health Score projections to 2020 (men = 7.4 [95% CI, 5.7, 9.1]; women = 8.8 
[95% CI, 7.6, 9.9]) fall well below the level needed to achieve a 20% improvement (men = 9.4; 
women = 10.1).   
Conclusions - The AHA 2020 target of improving CV health by 20% by 2020 will not be 
reached if current trends continue. 
Key words: cardiovascular disease risk factors; epidemiology; risk factors; trends 
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Background
The American Heart Association (AHA) 2020 Strategic Impact Goals target a 20% relative 
improvement in overall cardiovascular (CV) health in all Americans using 4 health behavior 
(smoking, diet, physical activity, body weight) and 3 health factor (plasma glucose, cholesterol, 
blood pressure) metrics.1 The 2020 goals were conceptualized on the basis of three key concepts 
of health promotion and disease prevention: 1) effectiveness of primordial prevention; 2) 
lifecourse nature of cardiovascular disease (CVD) development and CVD risk factors; 3) balance 
between population- and individual-level prevention.1 A higher number of health behaviors and 
factors at ideal levels is associated with substantially lower CV event rates in short- and long-
term follow up.1, 2 However, given the very low prevalence of individuals with ideal CV health,3 
a 20% relative improvement would have a small absolute effect on the population. Concurrent 
shifts from poor to intermediate levels of health behaviors and factors will also be able needed to 
realize substantial improvements across the spectrum of CV health. The 20% target was deemed 
aggressive yet achievable by consensus.1  
 Current trends of these composite CV health metrics are unclear.  Decreases in smoking4 
and exposure to secondhand smoke5 have slowed. Nationally representative data continue to 
suggest poor dietary quality for most of the population,6 but increases in obesity prevalence may 
be slowing.7 Trends in physical activity are mixed,4 but diabetes prevalence rates are rising.4 
Total cholesterol levels are decreasing, in part due to a doubling in the use of lipid-lowering 
drugs.8 Despite population-level increases in body weight, mean blood pressure and blood 
pressure control are improving.9  
 We therefore sought to evaluate recent trends in composite CV health metrics and to 
estimate future levels of CV health behaviors and factors among adults in the United States to  
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determine whether the AHA 2020 goals will be met if current trends continue. 
Methods
We used data from non-institutionalized, non-pregnant, non-lactating adults >20 years old in 
each age, sex, and race/ethnicity group as appropriate who were free from CVD and participated 
in the Third National Health and Nutrition Examination Survey (NHANES III, 1988-94) and 
subsequent two-year cycles (1999-2000, 2001-2, 2003-4, 2005-6, 2007-8).  Methods of 
measurement of each health behavior and health factor have been previously reported and are 
described in the Supplemental Methods.10 We defined CVD as any self-reported history of 
myocardial infarction, angina, stroke, or heart failure.  We calculated prevalence estimates from 
1988-2008 of ideal, intermediate, and poor levels of the 7 CV health behaviors and health 
factors, as defined by the AHA 2020 Impact Goals (Table 1).1  
Statistical Analyses 
All analyses were performed using SAS v9.1 (SAS Institute, Cary, NC) taking into account the 
complex sampling design. We used the standard 2000 US population to adjust the data for age 
using three age strata (20-39, 40-59 and >60 years). To estimate time trends from 1988 to 2008 
and average annual change in cardiovascular health factors and behaviors, we performed 
weighted linear regression using estimated mean values or percentages as dependent variables 
and survey time as independent variables.  We fitted weighted linear regression models with the 
prevalence as the dependent variables and survey time as independent variables. The beta 
coefficients indicate the average annual change in the prevalence. Based on the findings, we 
projected the future situation of year 2020 assuming that trends would continue to change at a 
similar rate. We calculated prediction intervals based on standard error (SE) of the predicted 
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prevalence estimates.  Reciprocals of variances were used as weights. We projected estimates to 
2020 by assuming that trends would continue similarly to those observed over the past two 
decades in a linear fashion.  Since the methodology used to measure diet and physical activity 
had changed from NHANES III to the 1999-2008 cycles, we excluded NHANES III dietary and 
physical activity data and only included data from 1999-2008.  Likewise, since the methodology 
used to measure physical activity changed between the 2005-6 and 2007-8 cycles, we excluded 
2007-8 cycle physical activity data.  We performed a sensitivity analysis by including individuals 
with CVD, and the overall prevalence trends and 2020 projections were not substantively 
different (<3% absolute difference in all 2020 projections including individuals with prevalent 
CVD). 
 We projected the situation for 2020 by assuming that trends would continue to change at 
a similar rate. We considered alternative statistical methods such as linear models with a 
quadratic term for time to assess non-linear trends, but the results differed little from standard 
linear models with the sole exception of blood pressure trends in women. The majority of our 
final estimated models had coefficients of determination (R2) value of 0.80 and better.  Results 
from log-linear and logit models were nearly identical to the results from linear models.  In 
additional, the projected 2020 estimates for blood pressure in women using a model with a 
quadratic term were substantially lower than a realistic value. Thus, we chose to use the linear 
models for simplicity.  Estimates with a coefficient of variation larger than 30% were considered 
as unreliable.11 Data are presented as mean and 95% CI.  A p value <0.05 defined statistical 
significance.  
 We compared these estimates based on current trends with a 20% improvement in CV 
health metrics from 2006 to 2020, since the AHA used 2006 as a reference point.  A 20% 
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improvement in CV health was defined as the average of a 20% relative decrease in the 
prevalence of poor CV health metrics and a 20% relative increase in the prevalence of ideal CV 
health across the 7 metrics. This method minimizes the likelihood of demonstrating an 
“improvement” in CV health that is solely driven by a reduction in poor health, which could be 
due to higher death rates in that group. Categories of ideal, intermediate, and poor levels of each 
metric are exclusive from each other. Thus, the prevalence estimates across different categories 
of each item (poor smoking, intermediate smoking and ideal smoking, for example) sum to 100% 
by definition.  For projections to 2020, we created estimates by first accounting for changes in 
ideal and poor levels of each metric and created estimates for intermediate levels based on the 
remaining prevalence.   
 In order to capture individual-level changes in CV health factors and behaviors, we 
created a composite, individual-level CV Health Score, based on the individual-level composite 
of all 7 CV health behaviors and health factors (poor=0 points; intermediate=1 point; ideal=2 
points; total scale: 0-14 points).  This score is not a risk prediction tool but helps to assess 
individual-level trends amidst population-level trends in CV health.  We assessed changes in the 
score from 1999 to 2006 and performed forward projections to 2020 in a similar manner.  We did 
not calculate CV Health Scores for NHANES III and for the 2007-8 cycle due to methodological 
differences in diet and physical activity data collection from 1999-2006. 
 
Results 
Among 79,932 participants who attended interviews and examination measurements from 1988 
to 2008, we analyzed data from up to 35,059 participants. Reasons for exclusion were: age <20 
years old (n=38,666, 48.4%), women pregnant or lactating (n=1,628, 2.0%), and prior 
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cardiovascular disease, defined as prior myocardial infarction, angina, stroke, or heart failure 
(n=4,579, 5.7%) (Supplemental Figure 1). Participants’ mean age was 44.4 years, and 51% 
were women.   
 Prevalence estimates for adults categorized as poor, intermediate, and ideal for CV health 
components in 1988-1994 and 2007-8 are displayed by sex in Tables 2 and 3.  In addition, ? 
coefficients and standard errors from weighted linear regression models, representing trends for 
each metric by including data from all NHANES samples, and coefficient of determination (R2), 
are displayed.  
 Prevalence of current smoking, physical activity (1999-2006 only), high cholesterol, and 
high blood pressure (i.e. – poor levels of these metrics) all decreased from 1988-2008, though 
trends in physical activity and in high blood pressure in women were not statistically significant, 
while a corresponding increase in ideal smoking status (never smoker or quit >12 months) was 
observed.  However, there was not a significant increase in the prevalence of individuals with 
ideal levels of physical activity, cholesterol, or blood pressure.  Conversely, obesity and 
dysglycemia increased substantially in both sexes from 1988-2008.  Furthermore, there was 
minimal increase in healthy diet score in men and no change in women during the period of 
observation (1999-2008).  
 Projected prevalence trends to 2020 (95% confidence intervals) for ideal, intermediate, 
and poor CV health metrics, assuming current trends continue, are also presented in Tables 2 
and 3 (right-hand columns).  Current smoking decreased significantly from 1998-2008 in both 
men and women with projected prevalence in 2020 reaching 23% in men and 16% in women.  
Prevalence of former smokers who had quit > 12 months ago or never smokers (ideal CV health) 
increased in both groups as well and is projected to be 4.5% and 4.3% in men and women in 
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2020.  Among current smokers, the mean number of cigarettes per day was lower in both men 
and women and in all age groups. (Supplemental Figure 2). 
 The prevalence of ideal healthy diet score=4 or 5 increased minimally from 0.3% to 0.6% 
in men (p=0.04) and from 0.9% to 1.4% in women (p=0.02) between 1999-2008.  The projected 
prevalence of ideal healthy diet score will reach only 1.2% in men and 1.9% in women by 2020.   
The mean healthy diet score was minimally increased between 1999-2008 in men (0.78 to 0.84 
healthy diet components; p=0.04) and in women (1.04 to 1.10; p=0.33). The healthy diet scores 
were slightly higher for adults > 60 years in both men and women from 2000 to 2006, but these 
differences were small and are projected to narrow further by 2020 (Supplemental Figure 3).  
 Physical inactivity prevalence declined non-significantly from 1999 to 2006 in both men 
(37% to 30%, p=0.40) and women (42% to 32%, p=0.87).  Corresponding increases in the 
prevalence of intermediate and ideal physical activity levels were also not statistically significant 
in either sex.  Projections to 2020 appear unreliable given fewer time periods and wide variance 
of this measure.  Median minutes of activity per week was <150 minutes in all age and sex 
groups from 2000 to 2006 (Supplemental Figure 4). 
 Mean BMI and obesity rates increased substantially from 20% in NHANES III to 32% by 
2007-8 in men and are projected to reach 43% by 2020 if current trends continue.  Similar trends 
were observed in women where 2020 prevalence projections of obesity reach 42%.  There was a 
corresponding rise in mean BMI and decrease in the prevalence of ideal BMI < 25 kg/m2 
(Supplemental Figure 5). 
 Trends in dysglycemia prevalence rates were similar.  Diabetes prevalence and impaired 
fasting glucose increased in both men and women.  The 2020 projected prevalence of diabetes is 
14% in men and 8% in women, and <50% of women and <25% of men will have ideal FPG 
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levels (<100 mg/dl).  Among individuals with diabetes, hemoglobin A1c values are projected to 
decrease  (7.5% to 7.2% from 2008 to 2020) in men, but remain stable in women (Supplemental 
Figure 6).  Among individuals without diabetes, the mean fasting plasma glucose increased to 
104 mg/dl in men and 99 mg/dl in women in 2008, with 2020 projections reaching 108 mg/dl 
and 101 mg/dl, respectively, if current trends continue (Supplemental Figure 7).   
 The mean total cholesterol fell from 204 mg/dl to 196 mg/dl in men and 206 mg/dl to 199 
mg/dl in women from 1998 to 2008.  By 2020, mean total cholesterol is projected to decrease in 
both men (to 191 mg/dl) and women (to 194 mg/dl) by 2020 (Supplemental Figure 8).  The 
corresponding prevalence of high cholesterol (>240 mg/dl) decreased from 19% to 14% in men 
(p<0.01) and from 21% to 15% in women (p<0.01) from 1988 to 2008.  However, the prevalence 
of individuals with intermediate cholesterol increased significantly. This group includes 
individuals with untreated levels of 200-239 mg/dl and those with total cholesterol <200 mg/dl 
on medical therapy (Supplemental Figures 9-10).   
 The prevalence of high blood pressure decreased from 21% to 16% in men (p<0.01) and 
from 17% to 13% in women (p=0.22) with a significant increase in the prevalence of 
intermediate levels of untreated blood pressure (120-139 mmHg systolic or 80-89 mmHg 
diastolic) or blood pressure treated to <140/<90 mmHg in women but not men. Mean systolic 
blood pressure is projected to be 119 mmHg in men and women by 2020.  Older adults (> 60 
years) had declines in mean systolic blood pressure, whereas middle-aged adults (40-59 years) 
and younger adults (20-39 years) did not (Supplemental Figure 11). Decreases in mean SBP 
over time were most pronounced among groups using blood pressure-lowering agents, in whom 
SBP was lower across all ages during all cycles (Supplemental Figures 12-13).  
Projections in CV Health: Will a 20% Improvement Be Achieved by 2020? 
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Figure 1 shows the prevalence of ideal (green), intermediate (yellow), and poor (red) CV health 
metrics in 2006 (AHA 2020 Impact Goals baseline year) and 2020 projections assuming current 
trends continue.  Additionally, Figure 1 provides 2020 targets for each CV health metric, 
assuming a 20% relative increase in ideal CV health prevalence metrics and a 20% relative 
decrease in poor CV health prevalence metrics for men and women.   
 Projected decreases in the prevalence of poor CV health will meet the 20% improvement 
if current trends continue for smoking, physical activity, blood pressure, and cholesterol.  
However, fewer and more modest increases in the prevalence of ideal CV health metrics are 
projected for smoking, diet, physical activity).  Overall, we estimate a 6.04% relative 
improvement in the prevalence of overall CV health based on current trends using the methods 
outlined by the AHA.  This would be well short of the AHA target. 
CV Health Score 
Figure 2 shows the distributions of the individual-based CV Health Score over 5 NHANES 
cycles from 1999-2006.  The highest overall mean score occurred during the 2005-6 cycle 
(yellow curves).  Furthermore, from 1999 to 2006, mean CV Health Scores did not significantly 
change for men (7.9 to 7.8 points; p=0.48) or women (8.2 to 8.4 points; p=0.46).  If these current 
trends continue to 2020, the mean scores are projected to be 7.4 (95% CI: 5.7, 9.1) for men and 
8.8 (95% CI: 7.6, 9.9) for women.  These estimates are substantially lower than the target scores 
necessary to achieve a 20% relative improvement in individual-level cardiovascular health (9.4 
for men; 10.1 for women).  
 
Discussion
Summary of Results 
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From 1988 to 2008, significant declines in the prevalence of smoking, high cholesterol, and high 
blood pressure (in men) have been offset by substantial increases in the prevalence of obesity 
and dysglycemia.  Healthy diet scores have changed minimally, and physical inactivity has 
trended lower, albeit not significantly.  The declines in high cholesterol and high blood pressure 
are not matched with a concomitant increase in the prevalence of ideal cholesterol and blood 
pressure levels, suggesting that individuals are moving toward intermediate levels of each health 
factor, a stratum that includes individuals treated to cholesterol and/or blood pressure target.   
 Worrying increases in BMI and dysglycemia are matched by a concomitant decrease in 
the prevalence of normal weight and euglycemic adults, consistently suggesting adverse 
population-level shifts in each metric.  Our projections may overestimate the future prevalence of 
impaired fasting glucose (intermediate CV health), since some individuals will likely develop 
diabetes by crossing the 126 mg/dl FPG threshold and will not contribute to these projected 
mean values.  
Implications
Our estimated 6% relative improvement in CV health from 2006 to 2020 is far short of the 
AHA’s 2020 Impact Goals’ target of improving CV health by 20%.  Furthermore, we project no 
changes in the mean individual CV Health Score for both men and women.  In addition to 
worsening CV health metrics, current trends will likely lead to stagnating age-adjusted fatal and 
non-fatal CVD event rates in the context of rising health care costs, based upon unfavorable 
coronary heart disease mortality trends among Americans aged 35-54 years old.12 The AHA has 
recently estimated that between 2010 and 2030 direct costs for CVD (including hypertension, 
coronary heart disease, heart failure, stroke, and all other CVD) will increase from $273 billion 
to $818 billion, while indirect costs will rise from $172 billion to $276 billion, unless substantial  
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changes to prevent and control CVD are adopted.13  
 The optimal combination of primordial,14 primary, and secondary prevention 
approaches—realized through a mixture of medical and public health/policy interventions—will 
be critical for any high functioning health system to reduce the prevalence of poor CV health 
metrics.  The goals of this approach are to 1) provide high quality, equitable management of 
individuals with risk factors and disease and 2) shift individuals from intermediate to ideal levels 
or, optimally, to maintain ideal health CV metrics throughout the lifespan. This has been shown 
to lead to greater longevity and health,15 compression of morbidity,16 dramatically low lifetime 
risks for CVD (which account for competing risks),17 and remarkably lower health care 
utilization and costs (annual, lifetime, and last-year-of-life).18 Given these compelling findings, 
the improvement in CV health through quantifiable metrics has received increasing attention, 
including being part of Healthy People 2020 as a named objective.19  
Potential targets for intervention 
These results reinforce the central importance of comprehensive tobacco control policies as well 
as the prevention and management of obesity through diet, exercise, and judicious use of 
therapies for weight loss to improve CV health in adults.  While declines in tobacco consumption 
are encouraging, tobacco remains the leading cause of preventable death and disability, including 
a substantial burden of non-CVD such as lung cancer and chronic lung disease.  The downstream 
impact of obesity on other CV health metrics such as dysglycemia, blood pressure, and possibly 
cholesterol suggests that reversal of body weight trends will have substantial benefits across the 
spectrum of CV health. 
 The World Health Organization has also prioritized tobacco control and healthier diet 
policies, suggesting several population-level “best buy” policy options for non-communicable, 
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chronic disease prevention that are relevant to the United States CV health and the AHA’s 2020 
Impact Goals. These include: 1) public smoking bans, 2) tobacco advertising restrictions, 3) 
increased tobacco excise taxes (especially relevant at the state level given the wide variation 
across the United States20), 4) reduced salt in the food supply, 5) replacement of trans fats with 
polyunsaturated fats, and 6) mass media campaigns to promote healthy diets and physical 
activity.21 In concert with policy changes, more rigorous improvements in individual lifestyle 
behaviors and factors and medical treatment and control (including combination therapy for 
high-risk individuals) are needed to help shift individuals from poor to intermediate to ideal CV 
health.19  
Strengths/Limitations 
The strengths of our results include its large, nationally representative sample size and 20 year 
measurement period.  However, our study has limitations.  First, measures of diet and physical 
activity are prone to sampling variability, as noted by the wide confidence intervals for these 
estimates, and misclassification due to self-reporting. In addition, we relied upon fewer 
NHANES cycles for trend tests and 2020 projections for diet and physical activity. Our estimates 
for diet and physical activity may be unstable and should be interpreted cautiously.  Second, 
future trends may not be linear, as we have assumed.  For example, recent obesity increases may 
be plateauing; conversely, recent cholesterol and blood pressure declines may also be plateauing, 
which may contribute to the flattening coronary heart disease mortality rates in young men and 
women in the US, UK and elsewhere.12, 22 Finally, we created a simple composite cardiovascular 
health score to examine individual-level cardiovascular health. This score weighs the presence of 
all intermediate or poor levels of the 7 metrics equally. Prior studies indicate that some adverse 
health factors, such as current smoking or diabetes, may be associated with greater relative risks 
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for cardiovascular events than other factors. However, the present score is not intended as a 
measure to estimate risk; rather, it serves as a means for monitoring the distribution (poor, 
intermediate or ideal) of all 7 metrics at the individual level across the population. Furthermore, 
Folsom et al.2 recently demonstrated that there were roughly equal step-wise decreases in 
hazards for cardiovascular events for each additional single health behavior or health factor 
present at ideal levels.  
 
Conclusions
If current trends continue, overall cardiovascular health is projected to improve by only 6% from 
2006 to 2020, far below the AHA 2020 Strategic Impact Goals target of 20%. This projection 
reflects modest, further declines in tobacco consumption, high cholesterol, and high blood 
pressure, offset by increases in obesity and dysglycemia.  Continued individual-level primary 
and secondary preventive measures should be complemented by an increased national 
commitment to promote primordial prevention. The potential reductions in cardiovascular 
disease burden if the AHA 2020 Impact Goals target of 20% improvement in overall CV health 
were achieved could be substantial, rapid, and associated with substantial cost savings.23-26
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Table 1. Definitions of cardiovascular health metrics, as defined by the American Heart Association’s 2020 Strategic Impact Goals 
committee. 
Level of Cardiovascular Health 
Metric Poor Intermediate Ideal 
Smoking Current smoker Quit smoking <12 months Never smoker or quit smoking >12 
months
Diet* Diet score = 0-1 Diet score = 2-3 Diet score = 4-5 
Physical Activity** No physical activity 1-149 minutes per week of moderate 
intensity, 1-74 minutes per week of 
vigorous intensity, or 1-149 moderate 
plus vigorous intensity activity 
(whereby time in vigorous activity is 
doubled)
(> 150 minutes per week of moderate 
intensity, > 75 minutes per week of 
vigorous intensity, or > 150 minutes per 
week of moderate plus vigorous intensity 
activity (in which time in vigorous 
activity is doubled)
Body Weight BMI > 30 kg/m2 BMI = 25-29.9 kg/m2 BMI < 25 kg/m2
Glucose/Diabetes FPG > 126 mg/dl or 
diagnosed diabetes 
mellitus with HbA1c >7%
FPG = 100-125 mg/dl or diagnosed 
diabetes mellitus with HbA1c <7%
Fasting plasma glucose (FPG) <100 
mg/dl
Cholesterol Total cholesterol >240 
mg/dl or treated total 
cholesterol >200 mg/dl
Total cholesterol = 200-239 mg/dl or 
treated to total cholesterol <200 mg/dl
Total cholesterol < 200 mg/dl
Blood Pressure Treated blood pressure 
<140/<90 mmHg, and 
SBP > 140 mmHg or DBP 
> 90 mmHg
SBP = 120-139 or DBP = 80-89, or 
treated blood pressure <140/<90 
mmHg
Blood pressure <120/<80 mmHg
*Diet score (scale: 0-5) was calculated based on one point for each of 5 components, including >4.5 cups per day of fruits/vegetables, >2 servings of fish per 
week (3.5 ounce servings), <1500mg per day of sodium, < 450 kcal (36 ounces) per week of sweets/sugar-sweetened beverages, and > 3 servings per day of 
whole grains (1.1 gram of fiber in 10 gram of carbohydrate; 1 ounce equivalent servings).   
**Leisure-time physical activity
BMI = body mass index; FPG = fasting plasma glucose; SBP = systolic blood pressure; DBP = diastolic blood pressure
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Table 2. Prevalence estimates (95% CI) and 2020 projections of poor, intermediate, and ideal levels of cardiovascular health 
components for US men: National Health and Nutrition Examination Surveys (1988-2008). 
NHANESIII (1988-1994) 2007-2008 ? ???? P value R2 2020 projection (95% CI) 
Smoking       
Poor  30.8 (27.9, 33.8) 25.6 (21.1, 30.2) -0.29 (0.08) 0.02 0.77 22.5 (16.5, 28.5) 
Intermediate  1.9 (1.0, 2.9) 2.7 (1.4, 4.0) 0.08†§ (0.04) 0.07 0.59 4.5 (1.5, 7.5) 
Ideal  67.3 (64.3, 70.2) 71.7 (67.7, 75.6) 0.21 (0.08) 0.05 0.65 73.0 (66.7, 79.3) 
Healthy Diet*       
Poor  82.5 (78.3, 86.6) 81.6 (78.7, 84.5) 0.03§ (0.15) 0.85 0.02 82.0 (72.5, 91.6) 
Intermediate  17.2 (13.2, 21.3) 17.8 (14.6, 21.0) -0.07§ (0.16) 0.71 0.05 16.8 (7.2, 26.5) 
Ideal  0.3 (0, 0.8) 0.6 (0, 1.2) 0.04† (0.01) 0.04 0.81 1.2 (0.3, 2.1) 
Physical Activity** 
Poor  36.8 (31.3, 42.2) 30.4 (24.0, 36.9) -0.80§ (0.69) 0.36 0.40 17.3 (0, 65.0) 
Intermediate  18.4 (14.4, 22.3) 20.2 (15.6, 24.8) 0.44§ (0.23) 0.19 0.65 26.6 (10.3, 42.9) 
Ideal  44.8 (38.4, 51.3) 49.4 (43.5, 55.2) 0.33§ (0.79) 0.72 0.10 56.1 (0, 100) 
Body Weight       
Poor  19.9 (17.5, 22.1) 31.6 (27.3, 36.0) 0.83 (0.07) < 0.01 0.97 43.4 (37.9, 49.4) 
Intermediate  41.2 (37.9, 44.1) 40.2 (35.8, 44.5) -0.05§ (0.07) 0.48 0.12 39.8 (34.5, 45.0) 
Ideal  38.9 (36.0, 42.4) 28.2 (25.1, 31.3) -0.75 (0.07) < 0.01 0.96 16.8 (11.7, 21.8) 
Glucose/Diabetes      
Poor  5.5 (4.1, 7.0) 11.1 (8.0, 14.3) 0.27† (0.08) 0.03 0.65 13.6 (4.9, 22.3) 
Intermediate  26.6 (23.2, 29.6) 50.5 (45.1, 55.9) 1.33 (0.28) < 0.01 0.85 63.1 (37.8, 88.3) 
Ideal  67.9 (64.8, 71.2) 38.4 (32.7, 44.0) -1.60 (0.34) < 0.01 0.85 23.3 (0, 53.7) 
Cholesterol       
Poor  18.6 (15.9, 20.8) 13.8 (10.8, 16.8) -0.30 (0.05) < 0.01 0.88 10.0 (5.7, 14.3) 
Intermediate  34.9 (31.9, 37.5) 39.6 (34.3, 44.8) 0.31 (0.08) 0.02 0.80 43.5 (37.3, 49.7) 
Ideal  46.5 (43.8, 50.0) 46.6 (41.6, 51.7) -0.01§ (0.12) 0.92 0.01 46.5 (37.0, 55.8) 
Blood Pressure      
Poor  21.0 (18.3, 23.5) 15.7 (12.8, 18.5) -0.35 (0.03) < 0.01 0.96 11.2 (8.3, 14.2) 
Intermediate  46.0 (42.6, 49.0) 48.6 (44.2, 53.0) 0.11§ (0.11) 0.40 0.18 48.7 (39.8, 57.7) 
Ideal  33.0 (30.6, 35.9) 35.7 (31.8, 39.6) 0.21§ (0.1.0) 0.10 0.53 40.1 (29.6, 50.4) 
* NHANES III data replaced with NHANES 1999-2000, given different methods used. 
**NHANES III and NHANES 2007-8 data replaced with NHANES 1999-2000 and 2005-6 data, respectively, given different methods used. 
†Coefficient of variation > 0.3. §P>0.05 for the null hypothesis that ?=0; all others, p<0.05. 
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Table 3. Prevalence estimates (95% CI) and 2020 projections of poor, intermediate, and ideal levels of cardiovascular health 
components for US women: National Health and Nutrition Examination Surveys (1988-2008). 
NHANESIII (1988-1994) 2007-2008 ? ???? P value R2 2020 projection (95% CI) 
Smoking       
Poor  25.3 (22.6, 27.8) 19.9 (16.0, 23.8) -0.33 (0.05) < 0.01 0.90 15.9 (11.6, 20.6) 
Intermediate  1.2 (0.6, 2.0) 2.7 (1.4, 4.0) 0.11† (0.02) < 0.01 0.90 4.2 (2.3, 6.3) 
Ideal  73.5 (70.6, 76.2) 77.4 (73.1, 81.6) 0.22 (0.05) < 0.01 0.85 79.9 (76.0, 83.6) 
Healthy Diet*       
Poor  71.2 (66.4, 75.9) 70.7 (67.0, 74.3) 0.03§ (0.19) 0.86 0.01 71.2 (58.8, 83.6) 
Intermediate  27.8 (23.2, 32.6) 27.9 (24.5, 31.3) -0.08§ (0.17) 0.67 0.07 26.9 (14.9, 38.9) 
Ideal  0.90 (0.01, 1.85) 1.4 (0.4, 0.4) 0.04† (0.02) 0.09 0.67 1.9 (0.8, 2.8) 
Physical Activity** 
Poor  42.2 (37.1, 47.4) 31.7 (26.6, 36.7) -1.70§ (0.47) 0.07 0.87 4.8 (0, 41.0) 
Intermediate  20.4 (14.8, 25.9) 25.3 (21.3, 29.4) 0.76§ (0.41) 0.21 0.64 40.2 (7.4, 73.0) 
Ideal  37.4 (30.5, 44.3) 43.0 (38.1, 47.8) 0.77§ (0.26) 0.09 0.82 55.0 (35.5, 74.6) 
Body Weight       
Poor  25.2 (22.2, 27.5) 34.1 (29.6, 38.6) 0.63 (0.09) < 0.01 0.92 42.2 (33.3, 51.0) 
Intermediate  25.8 (23.5, 28.1) 29.2 (25.0, 38.6) 0.15§ (0.10) 0.22 0.34 29.9 (20.9, 38.9) 
Ideal  49.0 (46.2, 52.4) 36.7 (32.5, 40.9) -0.78 (0.13) < 0.01 0.90 27.9 (15.5, 40.3) 
Glucose/Diabetes      
Poor  4.6 (3.3, 5.8) 6.3 (3.8, 8.8) 0.10†§ (0.05) 0.11 0.50 8.3 (2.2, 14.4) 
Intermediate  16.5 (14.0, 18.8) 36.6 (30.9, 42.2) 0.91 (0.24) 0.02 0.78 44.3 (21.9, 66.8) 
Ideal  78.9 (76.2, 81.8) 57.1 (51.2, 63.1) -1.07 (0.25) 0.01 0.82 47.4 (24.2, 70.5) 
Cholesterol       
Poor  21.1 (18.6, 23.5) 14.9 (11.7, 18.0) -0.40 (0.06) <0.01 0.92 10.0 (5.3, 14.8) 
Intermediate  31.3 (28.1, 34.0) 39.0 (35.8, 42.3) 0.48 (0.08) < 0.01 0.90 44.5 (37.8, 51.1) 
Ideal  46.1 (44.8, 50.9) 47.6 (42.2, 50.0) -0.08§ (0.08) 0.36 0.21 45.5 (39.2, 52.0) 
Blood Pressure      
Poor  16.9 (14.8, 19.0) 12.8 (10.3, 15.4) -0.21§ (0.14) 0.22 0.34 11.7 (0, 23.8) 
Intermediate  30.2 (27.5, 32.6) 35.9 (31.6, 40.3) 0.33 (0.06) < 0.01 0.85 39.4 (33.9, 44.8) 
Ideal  52.9 (50.6, 55.5) 51.2 (47.3, 55.2) -0.18§ (0.12) 0.20 0.36 48.9 (36.7, 61.0) 
* NHANES III data replaced with NHANES 1999-2000, given different methods used. 
**NHANES III and NHANES 2007-8 data replaced with NHANES 1999-2000 and 2005-6 data, respectively, given different methods used. 
†Coefficient of variation > 0.3. §P>0.05 for the null hypothesis that ?=0; all others, p<0.05.
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Figure Legends: 
Figure 1. Prevalence of ideal (green), intermediate (yellow), and poor (red) CV health metrics in 
2006 (AHA 2020 Impact Goals baseline year) and 2020 projections assuming current trends 
continue. 2020 targets for each CV health metric, assuming a 20% relative increase in ideal CV 
health prevalence metrics and a 20% relative decrease in poor CV health prevalence metrics for 
men and women. 
 
Figure 2. Distributions of the individual-based CV Health Score over 5 NHANES cycles from 
1999-2006.  
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 Supplemental Figures (14): Flowchart of participants (1); continuous variable data trends (13) 
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Supplemental Methods 
 
NHANES Methods of Measurement for Health Behaviors and Factors 
 Details regarding NHANES survey questionnaires, examination components and laboratory components 
are available at: http://www.cdc.gov/nchs/nhanes.htm. 
 
Health Behaviors 
 Participants were asked about smoking habits through the following questions, “Do you now smoke 
cigarettes?” and “How long has it been since you quit smoking cigarettes?”  Former smokers were divided into quit 
<12 months (intermediate CV health) and quit >12 months (ideal CV health). 
Participants were surveyed about their dietary habits from 1999-2008 through a combination of food frequency 
questionnaire and 24-hour dietary recall performed three to seven days following mobile examination center (MEC) 
examination.  Interviewees were provided a set of measuring guides to assist their recall.  Leisure-time physical 
activity was queried from 1999-2006 using the following questions, “Over the past 30 days, what moderate activity 
or activities did you do?” and “Over the past 30 days, how often did you perform (that activity)?”  Similar questions 
were asked regarding vigorous activities.  Activities were coded to estimate metabolic equivalents (METs) for 
moderate and vigorous activities. 
 
Health Factors 
 Height and weight were measured in a MEC examination with standardized equipment and techniques.  
Body mass index was calculated by dividing weight in kilograms by height in meters squared.  Diabetes was defined 
by fasting blood glucose > 126 mg/dl or affirmative response to one or more of the following questions: “Have you 
ever been told by a doctor that you have diabetes?  Are you now taking insulin?  Are you now taking diabetes pills 
to lower your blood sugar?”  Total cholesterol, HDL cholesterol, and triglycerides were measured in participants 
fasting >8 hours.  LDL cholesterol was measured using the Friedewald equation if triglycerides were <400 mg/dl 
(LDL cholesterol = total cholesterol – HDL cholesterol – triglycerides/5).  Medical treatment of high cholesterol was 
queried by asking, “To lower your blood cholesterol, have you ever been told by a doctor or other health 
professional to take prescribed medicine?” followed by “Are you now following this advice to take prescribed 
medicine?”  Blood pressure was measured by trained personnel using a mercury sphygmomanometer and an 
inflatable cuff at the level of the heart, after the participant rested for 5 minutes in a seated position with both feet on 
the floor.  Three blood pressure measurements were recorded and the mean of the last two recordings was used; if 
fewer than three measurements were performed, the second (if two) or first (if one) recording was used.  Medical 
treatment of elevated blood pressure was queried by asking, “Because of your hypertension/high blood pressure, 
have you ever been told to take a prescribed medicine?” followed by, “Are you now taking a prescribed medicine?”
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 Supplemental Figures. 
 
Supplemental Figure 1. Flowchart of participants from NHANES (1988-2008) included in analyses. 
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Supplemental Figure 2.  Trends for mean (SE) daily cigarette consumption among smokers in U.S. adults (>20 years) from 1991 to 
2008 and projected estimates for 2020 by sex and age group: National Health and Examination Surveys. 
(A) Men (B) Women
5
10
15
20
25
30
5
10
15
20
25
30
1990 1995 2000 2005 2010 2015 2020
20-39 years
40-59 years
>60 years
Year
Ci
ga
re
tt
es
/d
ay
1990 1995 2000 2005 2010 2015 2020
 
 at Galter Health Sciences Library on April 30, 2012http://circ.ahajournals.org/Downloaded from 
 
Supplemental Figure 3.  Trends for mean (SE) number of ideal Healthy Diet Score components in U.S. adults (>20 years) from 
2001 to 2008 and projected estimates for 2020 by sex and age group: National Health and Examination Surveys. 
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Supplemental Figure 4. Trends for median (SE) leisure time physical activity (minutes/week) in U.S. adults (>20 years) from 2001 to 
2008 and projected estimates for 2020 by sex and age group: National Health and Examination Surveys. 
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Supplemental Figure 5.  Trends for mean (SE) body mass index in U.S. adults (>20 years) from 1991 to 2008 and projected 
estimates for 2020 by sex and age group: National Health and Examination Surveys. 
 
(A) Men (B) Women
Year
Bo
dy
	  M
as
s	  I
nd
ex
	  (k
g/
m
2 )
25
26
27
28
29
30
31
32
1990 1995 2000 2005 2010 2015 2020
25
26
27
28
29
30
31
32
1990 1995 2000 2005 2010 2015 2020
20-39 years
40-59 years
>60 years
 
 
 
 
 
 
 
 at Galter Health Sciences Library on April 30, 2012http://circ.ahajournals.org/Downloaded from 
 
Supplemental Figure 6.  Trends for mean (SE) hemoglobin A1c in U.S. adults (>20 years) from 1991 to 2008 and projected 
estimates for 2020 by sex and age group: National Health and Examination Surveys. 
 
(A) Men
Year
H
em
og
lo
bi
n 
A
1c
 (%
)
(B) Women
4
5
6
7
8
9
10
11
12
1990 1995 2000 2005 2010 2015 2020
4
5
6
7
8
9
10
11
12
1990 1995 2000 2005 2010 2015 2020
20-39 years
40-59 years
>60 years
 
 at Galter Health Sciences Library on April 30, 2012http://circ.ahajournals.org/Downloaded from 
 
Supplemental Figure 7.  Trends for mean (SE) fasting blood glucose in U.S. adults (>20 years) without diabetes from 1991 to 2008 
and projected estimates for 2020 by sex and age group: National Health and Examination Surveys. 
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Supplemental Figure 8.  Trends for mean (SE) total cholesterol in U.S. adults (>20 years) from 1991 to 2008 and projected 
estimates for 2020 by sex and age group: National Health and Examination Surveys. 
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Supplemental Figure 9.  Trends for mean (SE) total cholesterol in UNTREATED U.S. adults (>20 years) from 1991 to 2008 and 
projected estimates for 2020 by sex and age group: National Health and Examination Surveys. 
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Supplemental Figure 10.  Trends for mean (SE) total cholesterol in TREATED U.S. adults (>20 years) from 1991 to 2008 and 
projected estimates for 2020 by sex and age group: National Health and Examination Surveys. 
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Supplemental Figure 11.  Trends for systolic blood pressure in U.S. adults (>20 years) from 1991 to 2008 and projected 
estimates for 2020 by sex and age group: National Health and Examination Surveys. 
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Supplemental Figure 12.  Trends for mean (SE) systolic blood pressure in UNTREATED U.S. adults (>20 years) from 1991 to 
2008 and projected estimates for 2020 by sex and age group: National Health and Examination Surveys. 
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Supplemental Figure 13.  Trends for mean (SE) systolic blood pressure in TREATED U.S. adults (>20 years) from 1991 to 2008 
and projected estimates for 2020 by sex and age group: National Health and Examination Surveys. 
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